Pilot ‘Olifantenpaadje’: faster route to Utrecht Science Park
During rush hour the cycle paths in the city centre heading towards Utrecht Science Park are very busy. From September, Utrecht municipality is testing a quieter route between Utrecht Central Station and Utrecht Science Park with the ‘Olifantenpaadje’ (desire line). The aim is to improve the distribution of cyclists and reduce crowds around popular routes.
The project is an initiative of two lecturers from the Hogeschool voor de Kunsten, Floor Bouwmeister and Friso van Booij, who won the bicycle spreading challenge of platform U-Forward with their idea ‘Utrechtse Olifantenpaadjes’. Together with Utrecht municipality, they designed signs equipped with a real-time pressure meter and advise on a quieter route, designated as ‘elephant path’. This alternative path bypasses busy points such as Tivoli and directs cyclists via the Ledig Erf, for example, a route that is just as fast and more comfortable despite the extra kilometre during rush hour. Congestion is indicated by colours: green (quiet), orange (normal) and red (busy).
With the pilot, which runs until the end of November 2024, the municipality wants to investigate whether cyclists find the signs useful and are willing to choose an alternative route. The alternative routes offer fewer intersections and traffic lights and pass through greener parts of the city. In this way, the municipality hopes to better regulate bicycle flows in Utrecht.
Full of energy toward the Utrecht Marathon: a successful running symposium filled with tips and inspiration
On March 19, the running symposium took place at UMC Utrecht, located at Utrecht Science Park, in the lead-up to the Utrecht Marathon on May 31. Many running enthusiasts who work or study at Utrecht Science Park attended the event that evening.
GenDx and Treos Bio Announce Partnership to develop HLA-based Companion Diagnostic for PolyPEPI1018 Cancer Immunotherapy
GenDx, a Eurobio Scientific Company, based in the Netherlands, specialized in molecular diagnostics for transplantation, today announced a collaboration with Treos Bio, a UK based clinical stage
company, developing next generation of effective off-the-shelf peptide cancer immunotherapies. GenDx and Treos Bio will partner in the development and validation of an integrated companion
diagnostic (CDx) HLA-typing test for Treos Bio’s off-the-shelf peptide cancer immunotherapy candidate, PolyPEPI1018, for the treatment of microsatellite stable (MSS) colorectal cancer.
Alan Hanjalic new Dean Faculty of Science
From 1 July 2026, prof. dr. Alan Hanjalic has been appointed Dean of the Faculty of Science by the Executive Board of Utrecht University (UU). He will also be appointed professor at UU. Currently, Hanjalic is professor of Computer Science and head of the Intelligent Systems department at TU Delft.
UtrechtInc has been recognized in the Financial Times “Europe’s Leading Startup Hubs 2026” ranking.
While UtrechtInc is proud of this recognition, the real stars of the story are the entrepreneurs, researchers, and students who walk through its doors every day.